Brief: Y-mAbs Reports Third Quarter 2022 Financial Results, Recent Corporate Developments

Y-mAbs Therapeutics

07/11/2022 21:59

Nov 7 (Reuters) - Y-mAbs Therapeutics Inc  YMAB.O :
    * Y-MABS REPORTS THIRD QUARTER 2022 FINANCIAL RESULTS AND
RECENT
CORPORATE DEVELOPMENTS
    * CASH POSITION OF $114.5 MILLION AS OF SEPTEMBER 30, 2022,
ANTICIPATED RUNWAY INTO MID-2024
    * REPORTED A NET LOSS FOR QUARTER ENDED SEPTEMBER 30, 2022
OF
$27.5 MILLION, OR $0.63 PER BASIC AND DILUTED SHARE
    * Q3 EARNINGS PER SHARE VIEW $-0.71 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX7DpvPp 
Further company coverage:  YMAB.O 
 ((Reuters.Briefs@thomsonreuters.com;))